United States · Bill · S
S. 1806 (104th)
A bill to amend the Federal Food, drug, and Cosmetic Act to clarify that any dietary supplement that claims to produce euphoria, heightened awareness or similar mental or psychological effects shall be treated as a drug under the Act, and for other purposes.
Introduced
23 May 1996
Last action
—
Status
Read twice and referred to the Committee on Labor and Human Resources.
Sponsors
—
Subjects
Discovery layer
Source updated
21 April 2025
Summary
Amends the Federal Food, Drug, and Cosmetic Act to consider a dietary supplement a drug if its labeling claims or implies that the supplement produces euphoria, heightened awareness, or similar mental or psychological effects.
This text is taken from the official record. PoliticalRepo does not editorialize.
Timeline
No timeline events have been ingested for this record yet.
Votes
No vote records are attached yet.
Versions
No version snapshots stored. Document URLs remain at the source.
Documents
3 official files
Introduced in Senate (text)
Introduced in Senate · EN · 23 May 1996
Introduced in Senate (PDF)
Introduced in Senate · EN · 23 May 1996
Introduced in Senate
summary · EN · 23 May 1996
Sponsors
No sponsors or actors listed by the source.
Related records
No cross-record relationships stored yet.
Sources
PoliticalRepo is an index and interpretation layer, not the authoritative legal source.
- Official source: https://www.congress.gov/bill/104th-congress/senate-bill/1806
- Open data entity: https://api.congress.gov/v3/bill/104/s/1806